Form D · Biotechnology

Neotx Holdings Ltd.

Rehovot, L3 · CIK 0001659794

Offering snapshot reported May 24, 2022 · SEC filing

Reported sold
$44.7M
Offering amount: $44.7M
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 5, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 24, 2022Initial$44,700,000No comparison0SEC filing
Oct 23, 2019Initial$37,897,965No comparison48SEC filing
Aug 21, 2019Amendment$9,229,901$6,736,005vs Dec 3, 201550SEC filing
Dec 18, 2018Initial$8,764,400No comparison20SEC filing
Dec 3, 2015Initial$2,493,896No comparison30SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-446781
Total offering amount represents the deemed value of Issuer's shares issued to InterX, Inc. shareholders in a merger, consisting of $4.7 million of common shares issued at closing, and $40 million of preferred shares to be issued post-closing.

Source: Form D, filed May 24, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Seo Yong Cho Director
Robert Harow Director, Executive
J. Tomilson Hill Director
Roger Kornberg Director
Paul Marinelli Director
Asher Nathan Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2 Pekeris St.
Rehovot, L3, 7670202